341 related articles for article (PubMed ID: 30987650)
1. Glucose-6-phosphate dehydrogenase blockade potentiates tyrosine kinase inhibitor effect on breast cancer cells through autophagy perturbation.
Mele L; la Noce M; Paino F; Regad T; Wagner S; Liccardo D; Papaccio G; Lombardi A; Caraglia M; Tirino V; Desiderio V; Papaccio F
J Exp Clin Cancer Res; 2019 Apr; 38(1):160. PubMed ID: 30987650
[TBL] [Abstract][Full Text] [Related]
2. Protective autophagy promotes the resistance of HER2-positive breast cancer cells to lapatinib.
Chen S; Zhu X; Qiao H; Ye M; Lai X; Yu S; Ding L; Wen A; Zhang J
Tumour Biol; 2016 Feb; 37(2):2321-31. PubMed ID: 26369543
[TBL] [Abstract][Full Text] [Related]
3. Her2-Targeted Therapy Induces Autophagy in Esophageal Adenocarcinoma Cells.
Janser FA; Adams O; Bütler V; Schläfli AM; Dislich B; Seiler CA; Kröll D; Langer R; Tschan MP
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30297650
[TBL] [Abstract][Full Text] [Related]
4. Autophagy stimulates apoptosis in HER2-overexpressing breast cancers treated by lapatinib.
Zhu X; Wu L; Qiao H; Han T; Chen S; Liu X; Jiang R; Wei Y; Feng D; Zhang Y; Ma Y; Zhang S; Zhang J
J Cell Biochem; 2013 Dec; 114(12):2643-53. PubMed ID: 23794518
[TBL] [Abstract][Full Text] [Related]
5. Autophagy inhibition facilitates erlotinib cytotoxicity in lung cancer cells through modulation of endoplasmic reticulum stress.
Wang Z; Du T; Dong X; Li Z; Wu G; Zhang R
Int J Oncol; 2016 Jun; 48(6):2558-66. PubMed ID: 27035631
[TBL] [Abstract][Full Text] [Related]
6. Isomahanine induces endoplasmic reticulum stress and simultaneously triggers p38 MAPK-mediated apoptosis and autophagy in multidrug-resistant human oral squamous cell carcinoma cells.
Utaipan T; Athipornchai A; Suksamrarn A; Chunsrivirot S; Chunglok W
Oncol Rep; 2017 Feb; 37(2):1243-1252. PubMed ID: 28075474
[TBL] [Abstract][Full Text] [Related]
7. PTK6 inhibition promotes apoptosis of Lapatinib-resistant Her2(+) breast cancer cells by inducing Bim.
Park SH; Ito K; Olcott W; Katsyv I; Halstead-Nussloch G; Irie HY
Breast Cancer Res; 2015 Jun; 17(1):86. PubMed ID: 26084280
[TBL] [Abstract][Full Text] [Related]
8. Effects of endoplasmic reticulum stress on the autophagy, apoptosis, and chemotherapy resistance of human breast cancer cells by regulating the PI3K/AKT/mTOR signaling pathway.
Zhong JT; Yu J; Wang HJ; Shi Y; Zhao TS; He BX; Qiao B; Feng ZW
Tumour Biol; 2017 May; 39(5):1010428317697562. PubMed ID: 28459209
[TBL] [Abstract][Full Text] [Related]
9. Induction of EnR stress by Melatonin enhances the cytotoxic effect of Lapatinib in HER2-positive breast cancer.
Sang X; Li L; Rui C; Liu Y; Liu Z; Tao Z; Cheng H; Liu P
Cancer Lett; 2021 Oct; 518():82-93. PubMed ID: 34153400
[TBL] [Abstract][Full Text] [Related]
10. Concurrent Autophagy Inhibition Overcomes the Resistance of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Human Bladder Cancer Cells.
Kang M; Lee KH; Lee HS; Jeong CW; Kwak C; Kim HH; Ku JH
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28165387
[TBL] [Abstract][Full Text] [Related]
11. Development of acquired resistance to lapatinib may sensitise HER2-positive breast cancer cells to apoptosis induction by obatoclax and TRAIL.
Eustace AJ; Conlon NT; McDermott MSJ; Browne BC; O'Leary P; Holmes FA; Espina V; Liotta LA; O'Shaughnessy J; Gallagher C; O'Driscoll L; Rani S; Madden SF; O'Brien NA; Ginther C; Slamon D; Walsh N; Gallagher WM; Zagozdzon R; Watson WR; O'Donovan N; Crown J
BMC Cancer; 2018 Oct; 18(1):965. PubMed ID: 30305055
[TBL] [Abstract][Full Text] [Related]
12. HER2-positive breast cancer cells resistant to trastuzumab and lapatinib lose reliance upon HER2 and are sensitive to the multitargeted kinase inhibitor sorafenib.
Valabrega G; Capellero S; Cavalloni G; Zaccarello G; Petrelli A; Migliardi G; Milani A; Peraldo-Neia C; Gammaitoni L; Sapino A; Pecchioni C; Moggio A; Giordano S; Aglietta M; Montemurro F
Breast Cancer Res Treat; 2011 Nov; 130(1):29-40. PubMed ID: 21153051
[TBL] [Abstract][Full Text] [Related]
13. Targeting glucose-6-phosphate dehydrogenase by 6-AN induces ROS-mediated autophagic cell death in breast cancer.
Li Y; Zheng F; Zhang Y; Lin Z; Yang J; Han X; Feng Y; Pei X; Li F; Liu Q; Yan L; Li T; Zhang Y; Li D; Fu Z; Wang C; Sun Q; Li C
FEBS J; 2023 Feb; 290(3):763-779. PubMed ID: 36048131
[TBL] [Abstract][Full Text] [Related]
14. A new inhibitor of glucose-6-phosphate dehydrogenase blocks pentose phosphate pathway and suppresses malignant proliferation and metastasis in vivo.
Mele L; Paino F; Papaccio F; Regad T; Boocock D; Stiuso P; Lombardi A; Liccardo D; Aquino G; Barbieri A; Arra C; Coveney C; La Noce M; Papaccio G; Caraglia M; Tirino V; Desiderio V
Cell Death Dis; 2018 May; 9(5):572. PubMed ID: 29760380
[TBL] [Abstract][Full Text] [Related]
15. HO-1 drives autophagy as a mechanism of resistance against HER2-targeted therapies.
Tracey N; Creedon H; Kemp AJ; Culley J; Muir M; Klinowska T; Brunton VG
Breast Cancer Res Treat; 2020 Feb; 179(3):543-555. PubMed ID: 31705351
[TBL] [Abstract][Full Text] [Related]
16. Lapatinib and obatoclax kill breast cancer cells through reactive oxygen species-dependent endoplasmic reticulum stress.
Cruickshanks N; Tang Y; Booth L; Hamed H; Grant S; Dent P
Mol Pharmacol; 2012 Dec; 82(6):1217-29. PubMed ID: 22989520
[TBL] [Abstract][Full Text] [Related]
17. Impaired pentose phosphate pathway in the development of 3D MCF-7 cells mediated intracellular redox disturbance and multi-cellular resistance without drug induction.
Wang W; Cai Q; Zhou F; Liu J; Jin X; Ni P; Lu M; Wang G; Zhang J
Redox Biol; 2018 May; 15():253-265. PubMed ID: 29291545
[TBL] [Abstract][Full Text] [Related]
18. Bortezomib blocks the catabolic process of autophagy via a cathepsin-dependent mechanism, affects endoplasmic reticulum stress and induces caspase-dependent cell death in antiestrogen-sensitive and resistant ER+ breast cancer cells.
Periyasamy-Thandavan S; Jackson WH; Samaddar JS; Erickson B; Barrett JR; Raney L; Gopal E; Ganapathy V; Hill WD; Bhalla KN; Schoenlein PV
Autophagy; 2010 Jan; 6(1):19-35. PubMed ID: 20110775
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia/HIF1α induces lapatinib resistance in ERBB2-positive breast cancer cells via regulation of DUSP2.
Karakashev SV; Reginato MJ
Oncotarget; 2015 Feb; 6(4):1967-80. PubMed ID: 25596742
[TBL] [Abstract][Full Text] [Related]
20. Tyrosine kinase inhibitors gefitinib, lapatinib and sorafenib induce rapid functional alterations in breast cancer cells.
Carloni S; Fabbri F; Brigliadori G; Ulivi P; Silvestrini R; Amadori D; Zoli W
Curr Cancer Drug Targets; 2010 Jun; 10(4):422-31. PubMed ID: 20384581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
